Statements (29)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:biotechnology
|
| gptkbp:CEO |
Rajeev Juneja
|
| gptkbp:country |
gptkb:India
|
| gptkbp:foundedIn |
1995
|
| gptkbp:founder |
R. C. Juneja
|
| gptkbp:headquartersLocation |
gptkb:New_Delhi
|
| https://www.w3.org/2000/01/rdf-schema#label |
Mankind Pharma
|
| gptkbp:industry |
pharmaceuticals
|
| gptkbp:IPODate |
2023
|
| gptkbp:market |
gptkb:India
international markets |
| gptkbp:notableProduct |
gptkb:Manforce_Condoms
Prega News Unwanted 72 |
| gptkbp:numberOfEmployees |
over 16,000
|
| gptkbp:parentCompany |
Mankind Group
|
| gptkbp:products |
veterinary medicines
OTC products pharmaceutical formulations |
| gptkbp:revenue |
over ₹8,000 crore (FY 2022-23)
|
| gptkbp:stockExchange |
gptkb:NSE
BSE |
| gptkbp:stockSymbol |
MANKIND
|
| gptkbp:subsidiary |
Lifestar Pharma
Mankind Wellness |
| gptkbp:type |
gptkb:public_company
|
| gptkbp:website |
https://www.mankindpharma.com/
|
| gptkbp:bfsParent |
gptkb:Manforce_Condoms
|
| gptkbp:bfsLayer |
5
|